Geoffrey C. Gillespie - 05 Jan 2024 Form 4 Insider Report for Orthofix Medical Inc. (OFIX)

Role: VP, Controller, Interim CFO
Signature: /s/ Geffrey Gillespie
Issuer symbol: OFIX
Transactions as of: 05 Jan 2024
Net transactions value: +$56,687
Form type: 4
Filing time: 09 Jan 2024, 18:24:15 UTC
Previous filing: 19 Dec 2023
Next filing: 19 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OFIX	Common Stock	Tax liability	$5,816	-459	-1.4%	$12.67	32,682	05 Jan 2024	Direct	F1
transaction	OFIX	Common Stock	Award	$62,503	+4,703	+14%	$13.29	37,385	08 Jan 2024	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OFIX	Employee Stock Option (Right to Buy)	Award	$0	+10,967		$0.000000	10,967	08 Jan 2024	Common Stock	10,967	$13.29	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 31,423 previously reported unvested restricted stock units.
F2	The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date.
F3	The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first anniversary of the Grant Date and one-twelfth (1/12th) of the shares covered thereby on each of the 15-month, 18-month, 21-month, 24-month, 27-month, 30-month, 33-month and 36-month anniversaries of the Grant Date.